




Searching News Database: Genesis
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 20 May 2024
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
Chroma Medicine Announces Appointment of Jenny Marlowe, Ph.D., as Chief Development Officer
HSMN NewsFeed - 5 Oct 2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
HSMN NewsFeed - 9 Nov 2022
Odyssey Therapeutics Expands Management Team with Key Appointments in Research Development and Strategy
Odyssey Therapeutics Expands Management Team with Key Appointments in Research Development and Strategy
HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
HSMN NewsFeed - 22 Jun 2022
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
Angiex Strengthens its Leadership Team with the Appointment of Marty J. Duvall as Chief Executive Officer
HSMN NewsFeed - 30 Mar 2022
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
Omega Therapeutics Strengthens Team With Key Management Appointments To Support Its Growth
HSMN NewsFeed - 7 Feb 2022
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
HSMN NewsFeed - 24 Feb 2021
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
Clarus Therapeutics Appoints Richard 'Ric' Peterson as Chief Financial Officer
HSMN NewsFeed - 17 Nov 2020
SafKan Health Announces FDA 510(k) Clearance for First-of-its-Kind OtoSet(TM) Ear Cleaning System
SafKan Health Announces FDA 510(k) Clearance for First-of-its-Kind OtoSet(TM) Ear Cleaning System
HSMN NewsFeed - 26 Oct 2020
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
Armata Pharmaceuticals Appoints Mina Pastagia, MD, MS as Vice President of Clinical Development
HSMN NewsFeed - 26 May 2020
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
Elevar Therapeutics Appoints Mark Gelder, M.D. as Global Head of Medical Affairs
HSMN NewsFeed - 16 Mar 2020
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata
HSMN NewsFeed - 13 Feb 2020
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
INVO Bioscience Announces Appointment of Inger Britt Carlsson as VP of Medical Affairs
HSMN NewsFeed - 30 Sep 2019
Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics
Arix Bioscience plc: Arix Co-leads EUR 20 Million Series A Investment Round in STipe Therapeutics
HSMN NewsFeed - 9 Sep 2019
Zimmer Biomet Commences Commercial Release of Persona(R) Revision Knee System
Zimmer Biomet Commences Commercial Release of Persona(R) Revision Knee System
HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
HSMN NewsFeed - 19 Jun 2019
European Radiology Profiles Seno Medical's Ground-Breaking Breast Cancer Diagnostic Technology
European Radiology Profiles Seno Medical's Ground-Breaking Breast Cancer Diagnostic Technology
HSMN NewsFeed - 18 Jan 2019
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
Lilly Reports Results of Phase 3 Soft Tissue Sarcoma Study of LARTRUVO(R)
HSMN NewsFeed - 5 Nov 2018
Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology
Shoulder Innovations Announces FDA 510(k) Clearance For Shoulder Technology
HSMN NewsFeed - 13 Sep 2018
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
FDA to Review EYLEA (aflibercept) Injection for the Treatment of Diabetic Retinopathy
HSMN NewsFeed - 17 Aug 2018
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
FDA Approves EYLEA(R) (aflibercept) Injection sBLA in Wet Age-related Macular Degeneration
HSMN NewsFeed - 19 Jul 2018
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 28 Jun 2018
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
Lupin and Mylan Partner to Commercialize Enbrel(R) (Etanercept) Biosimilar
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 5 Apr 2018
Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs
Former Acelity, J&J Executive Joins Organogenesis as Vice President of Global Medical & Clinical Affairs
HSMN NewsFeed - 13 Mar 2018
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
HSMN NewsFeed - 14 Feb 2018
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue
Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft(TM)C9T1 Skin Tissue
HSMN NewsFeed - 22 Jan 2018
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
Symic Bio Appoints Hicham Alaoui, Ph.D., as Senior Vice President of Discovery Biology
HSMN NewsFeed - 2 Nov 2017
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
Therapix Biosciences' Board Chairman, Ascher Shmulewitz, Appointed as Interim Chief Executive Officer
HSMN NewsFeed - 26 Oct 2017
Advanced Medical Solutions Group and Organogenesis Inc. Enter into Patent Out-licensing Agreement
Advanced Medical Solutions Group and Organogenesis Inc. Enter into Patent Out-licensing Agreement
HSMN NewsFeed - 19 Sep 2017
Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
HSMN NewsFeed - 12 Jul 2017
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
HSMN NewsFeed - 30 May 2017
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration
HSMN NewsFeed - 24 Apr 2017
Seno Medical Instruments Appoints Ann Waterhouse as VP, Quality Assurance and Regulatory Affairs
Seno Medical Instruments Appoints Ann Waterhouse as VP, Quality Assurance and Regulatory Affairs
HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
HSMN NewsFeed - 18 Aug 2016
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
FDA Grants Soligenix Orphan Drug Designation for Dusquetide for Treatment of Macrophage Activation Syndrome
HSMN NewsFeed - 11 Aug 2016
PrEP Biopharm Limited announces new CFO, Mike McGuinness, and new Head of CMC, Anna Slater
PrEP Biopharm Limited announces new CFO, Mike McGuinness, and new Head of CMC, Anna Slater
HSMN NewsFeed - 21 Jun 2016
Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer
Neurotrope Appoints Paula T. Trzepacz, M.D. as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 23 May 2016
Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
Zambon Launches Xadago(R) (Safinamide) in the U.K. for Patients with Mid- to Late-Stage Parkinson’s Disease
HSMN NewsFeed - 20 May 2016
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
Neuralstem Announces Plan of Reorganization to Further Align Business with Strategic Intent
HSMN NewsFeed - 29 Apr 2016
Stryker’s Spine Division Debuts 3D-Printed Tritanium(R) Posterior Lumbar Cage at AANS Meeting
Stryker’s Spine Division Debuts 3D-Printed Tritanium(R) Posterior Lumbar Cage at AANS Meeting
HSMN NewsFeed - 31 Mar 2016
GenesisCare and Elekta Sign Strategic Partnership for More Than USD 100 Million
GenesisCare and Elekta Sign Strategic Partnership for More Than USD 100 Million
HSMN NewsFeed - 16 Feb 2016
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
Neuralstem Appoints Richard Daly as President and Chief Executive Officer
HSMN NewsFeed - 12 Jan 2016
Zambon Launches Xadago(R) (Safinamide) in Switzerland for Patients with Parkinson’s Disease
Zambon Launches Xadago(R) (Safinamide) in Switzerland for Patients with Parkinson’s Disease
HSMN NewsFeed - 11 Jan 2016
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
Iconic Therapeutics Closes Series C Financing With New and Existing Investors
HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 17 Nov 2015
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
ARCH Venture Partners, Flagship Ventures and MD Anderson Collaborate to Launch Codiak BioSciences
HSMN NewsFeed - 26 Jun 2015
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
EYLEA(R) (aflibercept) Injection Receives Approval in Japan for the Treatment of Retinal Vein Occlusion
HSMN NewsFeed - 15 May 2015
Zambon Launches Xadago(R) (safinamide) for Patients with Mid- to Late-Stage Parkinson’s Disease in Germany
Zambon Launches Xadago(R) (safinamide) for Patients with Mid- to Late-Stage Parkinson’s Disease in Germany
HSMN NewsFeed - 14 Apr 2015
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
Eiger BioPharmaceuticals Announces Senior Staff Appointments in Clinical Development and Regulatory Affairs
HSMN NewsFeed - 31 Mar 2015
Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer
Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer
HSMN NewsFeed - 15 Jan 2015
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
Seres Health Appoints Shelley Trucksis, Ph.D., M.D. as Executive Vice President and Chief Medical Officer
HSMN NewsFeed - 14 Aug 2014
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
HSMN NewsFeed - 13 Aug 2014
Tarsa Therapeutics Secures $10 Million And Adds Industry Veteran Daniel Soland As A Director
Tarsa Therapeutics Secures $10 Million And Adds Industry Veteran Daniel Soland As A Director
HSMN NewsFeed - 11 Aug 2014
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)
HSMN NewsFeed - 7 Aug 2014
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
HSMN NewsFeed - 5 Aug 2014
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
Alzheon Appoints Renowned Industry Leader, Jean-Pierre Sommadossi, PhD, to Board of Directors
HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
HSMN NewsFeed - 7 Jul 2014
Nexavar(R) (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
Nexavar(R) (sorafenib tablets) now Approved in Canada for the Treatment of Differentiated Thyroid Cancer
HSMN NewsFeed - 19 Jun 2014
Tyrogenex Raises $15M in Series D Financing from Brace Pharma, US Investment Arm of EMS S/A
Tyrogenex Raises $15M in Series D Financing from Brace Pharma, US Investment Arm of EMS S/A
HSMN NewsFeed - 11 Jun 2014
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
Lilly Announces Top-Line Results Of Phase III Hepatocellular Carcinoma Trial
HSMN NewsFeed - 9 Jun 2014
Batu Biologics Announces FDA Development Plans for ValloVax(TM) Angiogenesis-Targeting Cancer Vaccine
Batu Biologics Announces FDA Development Plans for ValloVax(TM) Angiogenesis-Targeting Cancer Vaccine
HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
HSMN NewsFeed - 29 Apr 2014
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
CryoLife Receives FDA 510(k) Clearance for PerClot(R) Topical Hemostatic Powder in the U.S.
HSMN NewsFeed - 21 Apr 2014
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
Spectrum Pharmaceuticals Promotes and Appoints Joseph Turgeon as President and Chief Operating Officer
HSMN NewsFeed - 19 Feb 2014
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
HSMN NewsFeed - 20 Dec 2013
Synta Announces Appointment of Steven Bernitz as Senior Vice President, Corporate Development
Synta Announces Appointment of Steven Bernitz as Senior Vice President, Corporate Development
HSMN NewsFeed - 18 Nov 2013
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
Auxilium Announces Results of the XIAFLEX(R) in Dupuytren's MULTICORD Contracture Trial
HSMN NewsFeed - 23 Sep 2013
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
Bayer receives approval for Adempas(R) as first drug to treat rare heart and lung disease
HSMN NewsFeed - 12 Jun 2013
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
HSMN NewsFeed - 28 May 2013
Kala Pharmaceuticals Appoints Charles McDermott as Executive Vice President of Business Development
Kala Pharmaceuticals Appoints Charles McDermott as Executive Vice President of Business Development
HSMN NewsFeed - 15 May 2013
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
Bayer Initiates Phase III Trial of Stivarga(R) (regorafenib) Tablets in Patients with Advanced Liver Cancer
HSMN NewsFeed - 7 May 2013
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
Corgenix Gains CE Mark for ReLASV(R) Antigen Rapid Test for Diagnosis of Lassa Fever
HSMN NewsFeed - 21 Dec 2012
Spectrum Pharmaceuticals Announces Achievement of Primary Endpoint in Belinostat Registrational Trial
Spectrum Pharmaceuticals Announces Achievement of Primary Endpoint in Belinostat Registrational Trial
HSMN NewsFeed - 21 Nov 2012
OXiGENE Announces OXi4503 Granted Orphan Designation for Treatment of Acute Myelogenous Leukemia
OXiGENE Announces OXi4503 Granted Orphan Designation for Treatment of Acute Myelogenous Leukemia
HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
HSMN NewsFeed - 3 Oct 2012
St. Jude Medical's Peripheral Nerve Stimulation Study Confirms Benefit for Chronic Migraine Patients
St. Jude Medical's Peripheral Nerve Stimulation Study Confirms Benefit for Chronic Migraine Patients
HSMN NewsFeed - 27 Sep 2012
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 24 Sep 2012
Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development
Ventrus Biosciences Appoints JP Benya Vice President, Commercial Operations and Business Development
HSMN NewsFeed - 12 Sep 2012
New Knee Implant Is Changing The Way Patients And Surgeons View Revision Hinged Knee Replacement
New Knee Implant Is Changing The Way Patients And Surgeons View Revision Hinged Knee Replacement
HSMN NewsFeed - 2 Aug 2012
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
HSMN NewsFeed - 18 Jun 2012
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
HSMN NewsFeed - 16 May 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
Genentech Will Report New Data on Important Progress for People with Advanced Cancers at ASCO 2012
HSMN NewsFeed - 14 May 2012
FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Treatment of Wet-AMD
FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Treatment of Wet-AMD
HSMN NewsFeed - 8 May 2012
SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE
SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE
HSMN NewsFeed - 5 Apr 2012
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP(R) (aflibercept)
HSMN NewsFeed - 12 Mar 2012
Organogenesis Inc. Announces FDA Approval of GINTUIT(TM) for Oral Soft Tissue Regeneration
Organogenesis Inc. Announces FDA Approval of GINTUIT(TM) for Oral Soft Tissue Regeneration
HSMN NewsFeed - 6 Mar 2012
Islet Sciences Names Dr. George J. Todaro and Dr. Jerry L. Nader to Board of Directors
Islet Sciences Names Dr. George J. Todaro and Dr. Jerry L. Nader to Board of Directors
HSMN NewsFeed - 15 Feb 2012
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
Researchers Show TB4 Provides Both Neuroprotection and Neurorestoration after Traumatic Brain Injury
HSMN NewsFeed - 12 Oct 2011
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
Onyx Pharmaceuticals and Bayer Healthcare Restructure Global Oncology Partnership
HSMN NewsFeed - 5 Oct 2011
Major Diagnostic Breakthrough in Multiple Sclerosis Achieved with Advanced FONAR UPRIGHT(R) MRI
Major Diagnostic Breakthrough in Multiple Sclerosis Achieved with Advanced FONAR UPRIGHT(R) MRI
HSMN NewsFeed - 21 Sep 2011
Cytomedix Announces Publication of Data From Wound Outcomes Registry in the International Wound Journal
Cytomedix Announces Publication of Data From Wound Outcomes Registry in the International Wound Journal
HSMN NewsFeed - 19 Jul 2011
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
Allergan, Inc. to Acquire Privately Held Dermatologic Company, Vicept Therapeutics
HSMN NewsFeed - 21 Jun 2011
Kurt May to Join International Stem Cell Corporation as Senior Vice President
Kurt May to Join International Stem Cell Corporation as Senior Vice President
HSMN NewsFeed - 2 Jun 2011
ThermoGenesis Announces 510(k) Approval for Use of Res-Q in Preparation of Platelet Rich Plasma
ThermoGenesis Announces 510(k) Approval for Use of Res-Q in Preparation of Platelet Rich Plasma
HSMN NewsFeed - 20 May 2011
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
HSMN NewsFeed - 9 May 2011
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
HSMN NewsFeed - 9 May 2011
FDA Grants Orphan Drug Designation for Mithridion's MCD-386CR to Treat Progressive Supranuclear Palsy
FDA Grants Orphan Drug Designation for Mithridion's MCD-386CR to Treat Progressive Supranuclear Palsy
HSMN NewsFeed - 18 Apr 2011
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
HSMN NewsFeed - 8 Apr 2011
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
Regeneron and Bayer Announce Start of Phase 3 Clinical Program in Diabetic Macular Edema
HSMN NewsFeed - 24 Feb 2011
FDA Grants Genentech a Hearing on Avastin’s Use for Metastatic Breast Cancer in the United States
FDA Grants Genentech a Hearing on Avastin’s Use for Metastatic Breast Cancer in the United States
HSMN NewsFeed - 23 Feb 2011
Genesis Biopharma Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors
Genesis Biopharma Appoints L. Stephen Coles M.D., Ph.D. to Board of Directors
HSMN NewsFeed - 8 Feb 2011
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
Third Phase III Study of Avastin-Based Regimen Met Primary Endpoint in Ovarian Cancer
HSMN NewsFeed - 10 Jan 2011
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
Exelixis’ XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib
HSMN NewsFeed - 10 Jan 2011
Bioheart Reports Positive Results for Adipose Derived Stem Cells in Critical Limb Ischemia
Bioheart Reports Positive Results for Adipose Derived Stem Cells in Critical Limb Ischemia
HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
HSMN NewsFeed - 8 Oct 2010
Integra LifeSciences Features the Inforce(R) Reinforcement Matrix at the 65th Annual ASSH Meeting
Integra LifeSciences Features the Inforce(R) Reinforcement Matrix at the 65th Annual ASSH Meeting
HSMN NewsFeed - 27 Sep 2010
Pfizer Discontinues Phase 3 Trial of SUTENT(R) in Advanced Castration-Resistant Prostate Cancer
Pfizer Discontinues Phase 3 Trial of SUTENT(R) in Advanced Castration-Resistant Prostate Cancer
HSMN NewsFeed - 19 Aug 2010
Treatment with Elekta's Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia
Treatment with Elekta's Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia
HSMN NewsFeed - 22 Jun 2010
International Stem Cell Corporation Names Charles J. Casamento to Board of Directors
International Stem Cell Corporation Names Charles J. Casamento to Board of Directors
HSMN NewsFeed - 1 Jun 2010
Lorus Therapeutics Files Investigational New Drug Application With FDA for Anticancer Drug LOR-253
Lorus Therapeutics Files Investigational New Drug Application With FDA for Anticancer Drug LOR-253
HSMN NewsFeed - 6 May 2010
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
HSMN NewsFeed - 26 Apr 2010
ThermoGenesis Extends Global Reach for Bone Marrow Products With New Distribution Agreements
ThermoGenesis Extends Global Reach for Bone Marrow Products With New Distribution Agreements
HSMN NewsFeed - 12 Mar 2010
Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
Genentech Provides Update on Phase III Study of Avastin in Men With Late Stage Prostate Cancer
HSMN NewsFeed - 10 Mar 2010
SANUWAVE Health's Technology Shown to Successfully Treat Nonunion Fractures of the Tibia
SANUWAVE Health's Technology Shown to Successfully Treat Nonunion Fractures of the Tibia
HSMN NewsFeed - 25 Feb 2010
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
Genentech Announces Positive Results of Avastin Phase III Study in Women with Advanced Ovarian Cancer
HSMN NewsFeed - 11 Feb 2010
New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease
New Study Uses Adult Stem Cells in Effort to Save Limbs of Patients with Peripheral Arterial Disease
HSMN NewsFeed - 18 Jan 2010
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
St. Jude Medical Announces Approval and Launch of Neurostimulation System in Japan
HSMN NewsFeed - 1 Dec 2009
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
DiaMedica Proposes to Expand Into Neurological and Other Disorders Through Acquisition of Sanomune
HSMN NewsFeed - 18 Nov 2009
62-Year-Old Man Becomes First Patient in China Implanted with Rechargeable Neurostimulator for Chronic Pain
62-Year-Old Man Becomes First Patient in China Implanted with Rechargeable Neurostimulator for Chronic Pain
HSMN NewsFeed - 23 Oct 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Patients With Non-Responsive Thyroid Cancer
HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
HSMN NewsFeed - 5 Oct 2009
GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM)
GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT(TM)
HSMN NewsFeed - 18 Aug 2009
Kolltan Pharmaceuticals Expands Board of Directors and Senior Executive Team
Kolltan Pharmaceuticals Expands Board of Directors and Senior Executive Team
HSMN NewsFeed - 30 Jul 2009
Second Phase III Study Showed Lucentis Improved Vision in Patients With Retinal Vein Occlusion
Second Phase III Study Showed Lucentis Improved Vision in Patients With Retinal Vein Occlusion
HSMN NewsFeed - 30 Jul 2009
AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
HSMN NewsFeed - 30 Jul 2009
Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
Cardiogenesis Corporation Makes Pre-IDE Submission for PHOENIX Combination Delivery System
HSMN NewsFeed - 29 Jul 2009
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
HSMN NewsFeed - 27 Jul 2009
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
HSMN NewsFeed - 23 Jul 2009
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
HSMN NewsFeed - 11 Jun 2009
STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System
STAAR Surgical Receives FDA Clearance for the Epiphany(TM) Injector System
HSMN NewsFeed - 1 Jun 2009
Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer
Pfizer Discontinues SUN 1094 Trial of Sunitinib plus Paclitaxel in Advanced Breast Cancer
HSMN NewsFeed - 1 Jun 2009
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
Bayer and Onyx Initiate Phase 3 Trial of Nexavar in Non-Small Cell Lung Cancer
HSMN NewsFeed - 19 May 2009
TearLab Corporation Announces FDA 510(k) Clearance of the TearLab(tm) Osmolarity System
TearLab Corporation Announces FDA 510(k) Clearance of the TearLab(tm) Osmolarity System
HSMN NewsFeed - 30 Apr 2009
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
HSMN NewsFeed - 22 Apr 2009
Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint
Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint
HSMN NewsFeed - 30 Mar 2009
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
BrainCells Inc. Appoints Philip Jochelson, M.D. Chief Medical Officer and Jason Levin Chief Business Officer
HSMN NewsFeed - 11 Mar 2009
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
St. Jude Medical Announces European CE Mark Approval of Neurostimulation System for Chronic Angina
HSMN NewsFeed - 19 Feb 2009
Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
HSMN NewsFeed - 29 Jan 2009
FDA Provides Clear Path to NDA Submission for Pro-Pharmaceuticals’ DAVANAT(R)
FDA Provides Clear Path to NDA Submission for Pro-Pharmaceuticals’ DAVANAT(R)
HSMN NewsFeed - 22 Dec 2008
Myriad Genetics Launches Sixth Personalized Medicine Product, Prezeon -- to Reveal PTEN Status
Myriad Genetics Launches Sixth Personalized Medicine Product, Prezeon -- to Reveal PTEN Status
HSMN NewsFeed - 11 Dec 2008
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
New Data Shows Zometa(R) Enhances Impact of Chemotherapy on Reducing Breast Tumour Size
HSMN NewsFeed - 2 Dec 2008
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
Targeted Genetics Realigns Product Development Priorities and Implements Cost Reduction Measures
HSMN NewsFeed - 2 Dec 2008
Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
Cardiogenesis Announces Addition of Raymond W. Cohen to Board of Directors
HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
HSMN NewsFeed - 29 Oct 2008
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
ImClone Announces ERBITUX(R) Commercial Launch in Canada for Advanced Colorectal Cancer
HSMN NewsFeed - 21 Oct 2008
Tracon Pharmaceuticals Appoints Bryan Leigh, M.D. as Chief Medical Officer
Tracon Pharmaceuticals Appoints Bryan Leigh, M.D. as Chief Medical Officer
HSMN NewsFeed - 20 Oct 2008
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
Cardium Announces FDA 510(K) Clearance of InnerCool's RapidBlue(TM) Endovascular System
HSMN NewsFeed - 20 Oct 2008
Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
HSMN NewsFeed - 14 Oct 2008
Dr. Reddy's Wholly-Owned Subsidiary Promius Pharma Launches EPICERAM(R) Skin Barrier Emulsion
Dr. Reddy's Wholly-Owned Subsidiary Promius Pharma Launches EPICERAM(R) Skin Barrier Emulsion
HSMN NewsFeed - 23 Sep 2008
Vyteris Announces Growth Initiative Through Expanded Business Development Team
Vyteris Announces Growth Initiative Through Expanded Business Development Team
HSMN NewsFeed - 19 Sep 2008
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
ERBITUX(R) Now Available in Japan for Use in Treating Patients with Advanced Colorectal Cancer
HSMN NewsFeed - 18 Sep 2008
Enbrel(R) Shown to Deliver Long-Lasting Improvements in Psoriasis Patients' Quality of Life
Enbrel(R) Shown to Deliver Long-Lasting Improvements in Psoriasis Patients' Quality of Life
HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed - 9 Sep 2008
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
ThermoGenesis Announces Distribution Agreement for Bone Marrow Stem Cell Device
HSMN NewsFeed - 8 Sep 2008
VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma
VELCADE(R) (Black Triangle Drug) (bortezomib) Approved For Previously Untreated Multiple Myeloma
HSMN NewsFeed - 5 Sep 2008
Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL
Positive SPA Reply From the FDA for TopoTarget's Pivotal Trial With Belinostat in PTCL
HSMN NewsFeed - 3 Sep 2008
Genelabs Technologies, Inc. Announces Appointment of Frederick W. Driscoll as President and CEO
Genelabs Technologies, Inc. Announces Appointment of Frederick W. Driscoll as President and CEO
HSMN NewsFeed - 3 Sep 2008
Smith & Nephew Receives C1 Category Reimbursement Approval for OXINIUM(TM) in Japan
Smith & Nephew Receives C1 Category Reimbursement Approval for OXINIUM(TM) in Japan
HSMN NewsFeed - 3 Sep 2008
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
HSMN NewsFeed - 29 Aug 2008
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
ERBITUX(R) Phase 3 BMS-099 Lung Cancer Study Secondary Endpoint Update: Overall Survival Results Announced
HSMN NewsFeed - 28 Aug 2008
Veteran Healthcare Industry Executive Rick Smith Joins Allocade, Inc. as President and CEO
Veteran Healthcare Industry Executive Rick Smith Joins Allocade, Inc. as President and CEO
HSMN NewsFeed - 27 Aug 2008
Confirma and MEDRAD Partner to Advance Patient Care in the European Union
Confirma and MEDRAD Partner to Advance Patient Care in the European Union
HSMN NewsFeed - 16 Jul 2008
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
ERBITUX(R) (Cetuximab) Receives Approval in Japan for Use in Advanced Colorectal Cancer
HSMN NewsFeed - 15 Jul 2008
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
Additional items found! 500

Members Archive contains
500 additional stories matching:
Genesis
(Password required)
Genesis
(Password required)